| Announce Date | 02/04/2026 |
| EPS Normalized Actual | $3.5 (Beat by $0.11) |
| EPS GAAP Actual | $3.5 (Beat by $0.11) |
| Revenue Actual | $12.252B |
| Revenue Surprise | Beat by $12252M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Sep 2029 | 14 | 9.77 | 13.21896 | 14.82182 | 1 |
| Sep 2029 | 14.06 | 9.72 | 13.32472 | 14.84659 | 3 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 2.81 | 2.81 | 12.252B | 4.76% | 12252M |
| FQ3 2025 (Sep 2025) | -2.84 | -2.84 | 11.271B | 9.11% | 11271M |
| FQ2 2025 (Jun 2025) | 2.44 | 2.44 | 10.365B | 9.38% | 10365M |
| FQ1 2025 (Mar 2025) | 2.55 | 2.55 | 10.979B | 14.48% | 10979M |
| FQ4 2024 (Dec 2024) | 2.86 | 2.86 | 11.669B | 14.86% | 11669M |
| FQ3 2024 (Sep 2024) | 2.62 | 2.62 | 10.244B | 15.75% | 10244M |
| FQ2 2024 (Jun 2024) | 1.91 | 1.91 | 9.393B | 10.03% | 9393M |
| FQ1 2024 (Mar 2024) | 2.08 | 2.08 | 9.389B | 1.21% | 9389M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2029 (Dec 2029) | 2.8496 | -- | 2.60786 | 3.04312 | 10 |
| FQ2 2029 (Jun 2029) | 3.08395 | -- | 2.82233 | 3.29338 | 7 |
| FQ1 2029 (Mar 2029) | 2.8496 | -- | 2.64776 | 2.94198 | 7 |
| FQ4 2028 (Dec 2028) | 2.6979 | -- | 2.44554 | 2.82573 | 6 |
| FQ3 2028 (Sep 2028) | 2.93 | -- | 2.80405 | 3.0281 | 13 |
| FQ2 2028 (Jun 2028) | 2.9 | -- | 2.77534 | 2.99709 | 8 |
| FQ1 2028 (Mar 2028) | 2.89 | -- | 2.76577 | 2.98676 | 8 |
| FQ4 2027 (Dec 2027) | 3.19401 | -- | 2.89524 | 3.34534 | 5 |
| FQ3 2027 (Sep 2027) | 3.20021 | -- | 3.16389 | 3.34494 | 11 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2029 (Dec 2029) | 17.16B | -- | 16.04B | 18.06B | 8 |
| FQ2 2029 (Jun 2029) | 12.97B | -- | 12.12B | 13.64B | 8 |
| FQ1 2029 (Mar 2029) | 15.14B | -- | 14.31B | 15.51B | 8 |
| FQ4 2028 (Dec 2028) | 14.82B | -- | 13.75B | 15.36B | 5 |
| FQ3 2028 (Sep 2028) | 11.38B | -- | 11.01B | 11.68B | 12 |
| FQ2 2028 (Jun 2028) | 11.23B | -- | 10.86B | 11.52B | 12 |
| FQ1 2028 (Mar 2028) | 10.94B | -- | 10.57B | 11.22B | 12 |
| FQ4 2027 (Dec 2027) | 11.78B | -- | 10.93B | 12.21B | 6 |
| FQ3 2027 (Sep 2027) | 11.4B | -- | 11.3B | 11.8B | 20 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 2.81 | 2.81 | 100% | |
| FQ3 2025 (Sep 2025) | -2.84 | -2.84 | 100% | |
| FQ2 2025 (Jun 2025) | 2.44 | 2.44 | 100% | |
| FQ1 2025 (Mar 2025) | 2.55 | 2.55 | 100% | |
| FQ4 2024 (Dec 2024) | 2.86 | 2.86 | 100% | |
| FQ3 2024 (Sep 2024) | 2.62 | 2.62 | 100% | |
| FQ2 2024 (Jun 2024) | 1.91 | 1.91 | 100% | |
| FQ1 2024 (Mar 2024) | 2.08 | 2.08 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0B | $12.25B | $12252M | 100% |
| FQ3 2025 (Sep 2025) | $0B | $11.27B | $11271M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $10.37B | $10365M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $10.98B | $10979M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $11.67B | $11669M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $10.24B | $10244M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $9.39B | $9393M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $9.39B | $9389M | 100% |